Review

Mammalian cell lines used in Bioprocessing

Volume: 39 Number: 3 August 30, 2022
EN

Mammalian cell lines used in Bioprocessing

Abstract

Various number of expression and host systems are used in biologics manufacturing. The most commonly preferred systems are based on bacteria, yeast, mammalian cells, insect cells, and transgenic animals. A wide range of molecules including insulin, mAbs, vaccines and recombinant proteins are produced by using different kind of host systems. Because of several reasons impacting the product quality and yield, mammalian cells are utilized. Moreover, mammalian cells are generally used in virus based vaccine manufacturing. Chinese Hamster Ovary (CHO) is the most widely used cell line for high yield stable recombinant protein production, while Human Embronic Kidney (HEK) is favoured for transient transfection low yield protein manufacturing, viral based vaccine and gene and cell therapy related vector production. Other mammalian cell lines such as NSO, Sp2.0, Vero, MRC-5 and PerC.6 are also used in both recombinant protein and virus productions. Multiple modifications are carried out on industrial cell lines in order to make them more suitable both for high yield and high quality protein production. Thanks to all of these alterations, high productivity and quality levels are achieved in biotechnology industry.

Keywords

References

  1. 1 EvaluatePharma World Preview 2019, Outlook to 2024. [online] Available at: . 2 Tripathi, N. and Shrivastava, A., 2019. Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development. Frontiers in Bioengineering and Biotechnology, 7.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Review

Publication Date

August 30, 2022

Submission Date

April 21, 2022

Acceptance Date

June 5, 2022

Published in Issue

Year 2022 Volume: 39 Number: 3

APA
Ergen, N., & Tüfekçi, H. (2022). Mammalian cell lines used in Bioprocessing. Deneysel Ve Klinik Tıp Dergisi, 39(3), 884-892. https://izlik.org/JA23ZU34NS
AMA
1.Ergen N, Tüfekçi H. Mammalian cell lines used in Bioprocessing. J. Exp. Clin. Med. 2022;39(3):884-892. https://izlik.org/JA23ZU34NS
Chicago
Ergen, Nuri, and Halil Tüfekçi. 2022. “Mammalian Cell Lines Used in Bioprocessing”. Deneysel Ve Klinik Tıp Dergisi 39 (3): 884-92. https://izlik.org/JA23ZU34NS.
EndNote
Ergen N, Tüfekçi H (August 1, 2022) Mammalian cell lines used in Bioprocessing. Deneysel ve Klinik Tıp Dergisi 39 3 884–892.
IEEE
[1]N. Ergen and H. Tüfekçi, “Mammalian cell lines used in Bioprocessing”, J. Exp. Clin. Med., vol. 39, no. 3, pp. 884–892, Aug. 2022, [Online]. Available: https://izlik.org/JA23ZU34NS
ISNAD
Ergen, Nuri - Tüfekçi, Halil. “Mammalian Cell Lines Used in Bioprocessing”. Deneysel ve Klinik Tıp Dergisi 39/3 (August 1, 2022): 884-892. https://izlik.org/JA23ZU34NS.
JAMA
1.Ergen N, Tüfekçi H. Mammalian cell lines used in Bioprocessing. J. Exp. Clin. Med. 2022;39:884–892.
MLA
Ergen, Nuri, and Halil Tüfekçi. “Mammalian Cell Lines Used in Bioprocessing”. Deneysel Ve Klinik Tıp Dergisi, vol. 39, no. 3, Aug. 2022, pp. 884-92, https://izlik.org/JA23ZU34NS.
Vancouver
1.Nuri Ergen, Halil Tüfekçi. Mammalian cell lines used in Bioprocessing. J. Exp. Clin. Med. [Internet]. 2022 Aug. 1;39(3):884-92. Available from: https://izlik.org/JA23ZU34NS